.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Julphar
Dow
Merck
AstraZeneca
Cerilliant
QuintilesIMS
Moodys
Daiichi Sankyo
McKesson

Generated: June 25, 2017

DrugPatentWatch Database Preview

THIOTHIXENE HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Thiothixene Hydrochloride, and what generic Thiothixene Hydrochloride alternatives are available?

Thiothixene Hydrochloride is a drug marketed by Paco, Teva Pharms, Alpharma Us Pharms, Teva, and Cycle Pharms Ltd. and is included in six NDAs.

The generic ingredient in THIOTHIXENE HYDROCHLORIDE is thiothixene hydrochloride. There are five drug master file entries for this compound. Additional details are available on the thiothixene hydrochloride profile page.

Summary for Tradename: THIOTHIXENE HYDROCHLORIDE

Patents:0
Applicants:5
NDAs:6
Bulk Api Vendors: see list18
Clinical Trials: see list2,246
Patent Applications: see list2,752
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:THIOTHIXENE HYDROCHLORIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Paco
THIOTHIXENE HYDROCHLORIDE
thiothixene hydrochloride
CONCENTRATE;ORAL071917-001Sep 20, 1989DISCNNoNo► Subscribe► Subscribe
Alpharma Us Pharms
THIOTHIXENE HYDROCHLORIDE
thiothixene hydrochloride
CONCENTRATE;ORAL070969-001Oct 16, 1987DISCNNoNo► Subscribe► Subscribe
Paco
THIOTHIXENE HYDROCHLORIDE
thiothixene hydrochloride
CONCENTRATE;ORAL071939-001Dec 16, 1988DISCNNoNo► Subscribe► Subscribe
Teva Pharms
THIOTHIXENE HYDROCHLORIDE
thiothixene hydrochloride
CONCENTRATE;ORAL071554-001Oct 16, 1987DISCNNoNo► Subscribe► Subscribe
Cycle Pharms Ltd
THIOTHIXENE HYDROCHLORIDE INTENSOL
thiothixene hydrochloride
CONCENTRATE;ORAL073494-001Jun 30, 1992DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Dow
Cipla
Federal Trade Commission
UBS
Argus Health
Mallinckrodt
Moodys
Covington
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot